1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center

Documenti analoghi

• Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections
  di: Woolever, Nathan L., et al.
  Pubblicazione: (2020)
• PCR Cycle-Threshold-Derived Toxin Identifies Patients at Low-Risk for Complications of C. difficile Infection Who Do Not Require Treatment
  di: Hitchcock, Matthew, et al.
  Pubblicazione: (2017)
• 1092. Tuning Down Clostridioides difficile PCR Sensitivity Reduces Treatment for C. difficile Infection in Toxin-Negative Patients With No Increase in Adverse Outcomes
  di: Hitchcock, Matthew, et al.
  Pubblicazione: (2018)
• Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study
  di: Hogan, Catherine Anne, et al.
  Pubblicazione: (2020)
• Elimination of Aerosol Ribavirin Use in Immunocompromised Patients with Metapneumovirus and Parainfluenza Virus Infections
  di: Mui, Emily, et al.
  Pubblicazione: (2017)